The Melanoma Research Alliance (MRA), the largest non-profit funder of melanoma research worldwide, has appointed Marc Hurlbert, Ph.D. as the organization’s chief science officer. His role began November 1, 2018.

“I am honored to join the Melanoma Research Alliance as its next Chief Science Officer,” said Dr. Hurlbert. “It is a promising time for people diagnosed with melanoma, thanks in large part to MRA’s research investments that have helped to greatly expand available treatments. However, more work is needed to ensure treatments that work for all.”

Hurlbert comes to MRA after having spent more than a decade in breast cancer research.

“Dr. Hurlbert has an outstanding record as a scientist and leader and we could not be more delighted to have him join MRA,” said Debra Black, co-founder and chair of MRA. “His experience in medical research, deep knowledge of pharmacology, and ability to forge and build strategic partnerships will allow him to further propel MRA and its mission forward.”